These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2134624)

  • 1. von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Transfus Med Rev; 1990 Apr; 4(2):163-8. PubMed ID: 2134624
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS).
    Moake JL
    Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307
    [No Abstract]   [Full Text] [Related]  

  • 3. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor in thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Thromb Haemost; 1999 Aug; 82(2):592-600. PubMed ID: 10605756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma exchange therapy in patients with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Ikeda Y; Kikuchi M
    Nihon Rinsho; 1992 Jan; 50 Suppl():293-7. PubMed ID: 1578694
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Brain MC; Neame PB
    Semin Thromb Hemost; 1982 Jul; 8(3):186-97. PubMed ID: 6753155
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent observations on the pathophysiology of thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL
    Hematol Pathol; 1990; 4(4):197-201. PubMed ID: 2074261
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.
    Lämmle B; George JN
    Semin Hematol; 2004 Jan; 41(1):1-3. PubMed ID: 14727253
    [No Abstract]   [Full Text] [Related]  

  • 10. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology and management of thrombotic thrombocytopenic purpura.
    Ruggenenti P; Remuzzi G
    Eur J Haematol; 1996 Apr; 56(4):191-207. PubMed ID: 8641387
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura in childhood.
    Bouw MC; Dors N; van Ommen H; Ramakers-van Woerden NL
    Pediatr Blood Cancer; 2009 Oct; 53(4):537-42. PubMed ID: 19544391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of thrombocytopenic thrombotic purpura].
    Corte Buelga JR; Rodríguez Vicente P; García Gala JM; Alonso García AM; Martínez Revuelta E
    Sangre (Barc); 1997 Feb; 42(1):53-61. PubMed ID: 9229804
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
    Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
    Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TTP/HUS and VWF/ADAMTS-13].
    Fujimura Y
    Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
    [No Abstract]   [Full Text] [Related]  

  • 19. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL; Jarolím P
    Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic criteria and differential diagnosis of thrombotic thrombocytopenic purpura].
    Pardo Vigo A; Zamora de Pedro C; Hernández Jodra M
    Rev Clin Esp; 2000 Dec; 200(12):685-7. PubMed ID: 11234475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.